Agency Information Collection Activities: Proposed Collection: Public Comment Request Information Collection Request Title: Healthy Start Evaluation and Capacity Building Support, OMB No. 0906-xxxx-New, 78112-78114 [2022-27698]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
78112
Federal Register / Vol. 87, No. 244 / Wednesday, December 21, 2022 / Notices
determination means that FDA will not
begin procedures to withdraw approval
of abbreviated new drug applications
(ANDAs) that refer to this drug product,
and it will allow FDA to continue to
approve ANDAs that refer to the
product as long as they meet relevant
legal and regulatory requirements.
FOR FURTHER INFORMATION CONTACT:
Michelle Weiner, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 51, Rm. 6208,
Silver Spring, MD 20993–0002, 240–
402–0374, Michelle.Weiner@
fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Section
505(j) of the Federal Food, Drug, and
Cosmetic Act (FD&C Act) (21 U.S.C.
355(j)) allows the submission of an
ANDA to market a generic version of a
previously approved drug product. To
obtain approval, the ANDA applicant
must show, among other things, that the
generic drug product: (1) has the same
active ingredient(s), dosage form, route
of administration, strength, conditions
of use, and (with certain exceptions)
labeling as the listed drug, which is a
version of the drug that was previously
approved and (2) is bioequivalent to the
listed drug. ANDA applicants do not
have to repeat the extensive clinical
testing otherwise necessary to gain
approval of a new drug application
(NDA).
Section 505(j)(7) of the FD&C Act
requires FDA to publish a list of all
approved drugs. FDA publishes this list
as part of the ‘‘Approved Drug Products
With Therapeutic Equivalence
Evaluations,’’ which is known generally
as the ‘‘Orange Book.’’ Under FDA
regulations, drugs are removed from the
list if the Agency withdraws or
suspends approval of the drug’s NDA or
ANDA for reasons of safety or
effectiveness or if FDA determines that
the listed drug was withdrawn from sale
for reasons of safety or effectiveness (21
CFR 314.162).
A person may petition the Agency to
determine, or the Agency may
determine on its own initiative, whether
a listed drug was withdrawn from sale
for reasons of safety or effectiveness.
This determination may be made at any
time after the drug has been withdrawn
from sale, but it must be made prior to
FDA’s approval of an ANDA that refers
to the listed drug (§ 314.161 (21 CFR
314.161)). FDA may not approve an
ANDA that does not refer to a listed
drug.
ZYBAN (Bupropion Hydrochloride)
Tablets, Extended Release, 150
Milligrams, is the subject of NDA
020711, held by GlaxoSmithKline LLC,
VerDate Sep<11>2014
19:56 Dec 20, 2022
Jkt 259001
and initially approved on May 14, 1997.
ZYBAN is indicated as an aid to
smoking cessation treatment.
ZYBAN (Bupropion Hydrochloride)
Tablets, Extended Release, 150
Milligrams, is currently listed in the
‘‘Discontinued Drug Product List’’
section of the Orange Book.
Yichang Humanwell Pharmaceutical
Co., Ltd. submitted a citizen petition
dated April 18, 2022 (Docket No. FDA–
2022–P–0614), under 21 CFR 10.30,
requesting that the Agency determine
whether ZYBAN (Bupropion
Hydrochloride) Tablets, Extended
Release, 150 Milligrams, was withdrawn
from sale for reasons of safety or
effectiveness.
After considering the citizen petition
and reviewing Agency records and
based on the information we have at this
time, FDA has determined under
§ 314.161 that ZYBAN (Bupropion
Hydrochloride) Tablets, Extended
Release, 150 Milligrams, was not
withdrawn for reasons of safety or
effectiveness. The petitioner has
identified no data or other information
suggesting that this drug product was
withdrawn for reasons of safety or
effectiveness. We have carefully
reviewed our files for records
concerning the withdrawal of ZYBAN
(Bupropion Hydrochloride) Tablets,
Extended Release, 150 Milligrams, from
sale. We have also independently
evaluated relevant literature and data
for possible postmarketing adverse
events. We have found no information
that would indicate that this drug
product was withdrawn from sale for
reasons of safety or effectiveness.
Accordingly, the Agency will
continue to list ZYBAN (Bupropion
Hydrochloride) Tablets, Extended
Release, 150 Milligrams, in the
‘‘Discontinued Drug Product List’’
section of the Orange Book. The
‘‘Discontinued Drug Product List’’
delineates, among other items, drug
products that have been discontinued
from marketing for reasons other than
safety or effectiveness. FDA will not
begin procedures to withdraw approval
of approved ANDAs that refer to this
drug product. Additional ANDAs for
this drug product may also be approved
by the Agency as long as they meet all
other legal and regulatory requirements
for the approval of ANDAs. If FDA
determines that labeling for this drug
product should be revised to meet
current standards, the Agency will
advise ANDA applicants to submit such
labeling.
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
Dated: December 15, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022–27647 Filed 12–20–22; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection: Public
Comment Request Information
Collection Request Title: Healthy Start
Evaluation and Capacity Building
Support, OMB No. 0906–xxxx—New
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In compliance with of the
Paperwork Reduction Act of 1995,
HRSA has submitted an Information
Collection Request (ICR) to the Office of
Management and Budget (OMB) for
review and approval. Comments
submitted during the first public review
of this ICR will be provided to OMB.
OMB will accept further comments from
the public during the review and
approval period. OMB may act on
HRSA’s ICR only after the 30-day
comment period for this Notice has
closed.
SUMMARY:
Comments on this ICR must be
received no later than January 20, 2023.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under Review—Open for
Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request a copy of the clearance requests
submitted to OMB for review, email
Samantha Miller, the acting HRSA
Information Collection Clearance Officer
at paperwork@hrsa.gov or call 301–594–
4394.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title:
Healthy Start Evaluation and Capacity
Building Support, OMB No. 0906–
xxxx—New.
Abstract: The National Healthy Start
Program, authorized by 42 U.S.C. 254c–
8 (section 330H of the Public Health
Service Act) and funded through HRSA,
has the goal of reducing disparities in
DATES:
E:\FR\FM\21DEN1.SGM
21DEN1
78113
Federal Register / Vol. 87, No. 244 / Wednesday, December 21, 2022 / Notices
maternal and infant health. The program
began as a demonstration project with
15 grantees in 1991 and has expanded
over the past 3 decades to 101 grantees
across 35 states; Washington, DC; and
Puerto Rico. Healthy Start grantees
operate in communities with rates of
infant mortality at least 1.5 times the
U.S. national average, or with high rates
of other adverse perinatal outcomes
(e.g., low birthweight, preterm birth).
Grantees may also qualify for the
program if their project areas meet other
relevant criteria (e.g., high rates of
diabetes, obesity, or tobacco use during
pregnancy; low utilization of prenatal
care in the first trimester; no utilization
of prenatal care during pregnancy) that
demonstrate disparities in health
outcomes for pregnant women in their
communities. Healthy Start programs
are located in communities that are
geographically, racially, ethnically, and
linguistically diverse. Healthy Start
covers services during the perinatal
period (before, during, after pregnancy)
and follows the women, infants, and
fathers/partners in the program through
18 months after the end of the
pregnancy. The Healthy Start program
uses a life course approach that includes
women’s health, family health and
wellness, and community/population
health.
HRSA seeks to implement a mixedmethods evaluation to assess the
effectiveness of the program on
individual, organizational, and
community-level outcomes. Data
collection instruments will include the
(1) Healthy Start Program Survey, (2)
Healthy Start Network Survey, (3)
Healthy Start Participant Survey, and (4)
Healthy Start Stakeholder Interview
Guide. These instruments have been
specifically designed to be nonduplicative. Using previously approved
content, the Healthy Start Program
Survey is designed to collect
information on the experiences of all
101 grantee programs related to program
infrastructure, services/activities,
participants, community partnerships,
new maternal and fatherhood
initiatives, and health equity. The
information collected in the survey will
allow the Healthy Start grantees to
better assess risk, identify needed
services, provide appropriate follow-up
activities to program participants, and
improve overall service delivery and
quality.
The two other surveys and interview
guide will be administered to a subset
of 15 grantees, their community
partners, and participants. The Healthy
Start Network Survey focuses on
understanding the participation of
members in the Healthy Start
Community Action Networks (CANs) 1
and collaborations within the CANs to
improve maternal, infant, and family
outcomes within the Healthy Start
communities. Results from the survey
will help the Healthy Start programs
and their CANs identify areas of
strength and opportunities for further
collaborations, understand how well the
CAN members are working together to
serve women and their families, and
whether they are supporting the
programs in addressing the participants’
greatest needs. The Healthy Start
Participant Survey is designed to collect
information about the experiences of the
Healthy Start participants with the
program and assess whether the
programs are meeting their needs. The
Healthy Start grantees can use this
information to identify areas to
strengthen the services provided to the
participants. The Healthy Start
Stakeholder Interview Guide is designed
to collect more in-depth information
about the Healthy Start services, the
new maternal health and fatherhood
initiatives, CAN activities, and activities
developed to improve the Healthy Start
benchmarks and achieve health equity.
A 60-day notice was published in the
Federal Register, 87 FR 43535 (July 21,
2022). There were no public comments.
Need and Proposed Use of the
Information: The purpose of the data
collection instruments is to obtain
consistent information across all
grantees about Healthy Start, its
operations and outcomes. The data will
be used to (1) conduct ongoing
performance monitoring of the program;
(2) provide credible and rigorous
evidence of program effect on outcomes;
(3) meet program needs for
accountability, programmatic decisionmaking, and ongoing quality assurance;
and (4) strengthen the evidence base
and identify best and promising
practices for the program to support
sustainability, replication, and
dissemination of the program.
Likely Respondents: Respondents will
include project directors and staff for
the Healthy Start Program Survey,
members of the CANs for the Healthy
Start Network Survey, program
participants for the Healthy Start
Participant Survey, and program and
administrative staff for the Healthy Start
Stakeholder Interview Guide.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions; to utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
The total annual burden hours
estimated for this ICR are summarized
in the table below. The total number of
responses was multiplied by the average
burden per response and summed to
produce the total annualized burden
hours, which is estimated to be 600
hours. A break-down of these hours is
detailed in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
lotter on DSK11XQN23PROD with NOTICES1
Form name
Healthy
Healthy
Healthy
Healthy
Start
Start
Start
Start
Program Survey .............................................
Network Survey .............................................
Participant Survey ..........................................
Stakeholder Interview Guide .........................
Total ..............................................................................
1 This
Number of
responses per
respondent
101
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
3 150
1
1
1
1
101
600
750
150
1.00
0.33
0.25
0.75
101
198
188
113
1,601
........................
1,601
........................
600
1 600
2 750
is the maximum number of responses for this data collection instrument.
1 A CAN is an existing, formally organized
partnership of organizations and individuals. The
CAN represents consumers and appropriate
VerDate Sep<11>2014
19:56 Dec 20, 2022
Jkt 259001
agencies which unite in an effort to collectively
apply their resources to the implementation of one
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
or more common strategies to achieve a common
goal within that project area.
E:\FR\FM\21DEN1.SGM
21DEN1
78114
Federal Register / Vol. 87, No. 244 / Wednesday, December 21, 2022 / Notices
2 Ibid.
3 Ibid.
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions; (2) the accuracy of the
estimated burden; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022–27698 Filed 12–20–22; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection: Public
Comment Request Information
Collection Request Title: Nurse Corps
Loan Repayment Program; OMB No.
0915–0140 Extension
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In compliance with the
requirement for opportunity for public
comment on proposed data collection
projects of the Paperwork Reduction Act
of 1995, HRSA announces plans to
submit an Information Collection
Request (ICR), described below, to the
Office of Management and Budget
(OMB). Prior to submitting the ICR to
OMB, HRSA seeks comments from the
public regarding the burden estimate,
below, or any other aspect of the ICR.
SUMMARY:
Comments on this ICR should be
received no later than January 20, 2023.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under Review—Open for
Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request a copy of the clearance requests
submitted to OMB for review, email
Samantha Miller, the acting HRSA
Information Collection Clearance Officer
at paperwork@hrsa.gov or call 301–594–
4394.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the ICR title
for reference.
Information Collection Request Title:
Nurse Corps Loan Repayment Program
(Nurse Corps LRP), OMB No. 0915–
0140—Extension.
Abstract: The Nurse Corps LRP assists
in the recruitment and retention of
professional Registered Nurses (RNs),
including Advanced Practice Registered
Nurses (APRNs), by decreasing the
financial barriers associated with
pursuing a nursing education. RNs in
this instance include APRNs (e.g., nurse
practitioners, certified registered nurse
anesthetists, certified nurse-midwives,
and clinical nurse specialists) dedicated
to working at eligible health care
facilities with a critical shortage of
nurses (i.e., a Critical Shortage Facility)
or working as nurse faculty in eligible,
accredited schools of nursing. The
Nurse Corps LRP provides loan
repayment assistance to these nurses to
repay a portion of their qualifying
educational loans in exchange for fulltime service at a public or private
DATES:
Critical Shortage Facility or in an
eligible, accredited school of nursing.
A 60-day notice published in the
Federal Register on September 29, 2022,
vol. 87, No. 188; pp. 59106–07. There
were no public comments.
Need and Proposed Use of the
Information: Individuals must submit
an application in order to participate in
the program. The application asks for
personal, professional, educational, and
financial information required to
determine the applicant’s eligibility to
participate in the Nurse Corps LRP. This
information collection is used by the
Nurse Corps program to make award
decisions about Nurse Corps LRP
applicants and to monitor a
participant’s compliance with the
program’s service requirements. The
Nurse Corps LRP is requesting an
extension and is seeking to use the
previously approved forms.
Likely Respondents: Professional RNs
or APRNs who are interested in
participating in the Nurse Corps LRP,
and official representatives at their
service sites.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel to be able to respond to a
collection of information; to search data
sources; to complete and review the
collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
respondents
lotter on DSK11XQN23PROD with NOTICES1
Form name
Number of
responses per
respondent
Total
responses
Average
burden
per response
(in hours)
Total burden
hours
Nurse Corps LRP Application * ............................................
Authorization to Release Information Form ** .....................
Employment Verification Form ** .........................................
Disadvantaged Background Form .......................................
Confirmation of Interest Form ..............................................
7,100
7,100
7,100
450
500
1
1
1
1
1
7,100
7,100
7,100
450
500
2.00
.10
.10
.20
.20
14,200
710
710
90
100
Total for Applicants .......................................................
22,250
........................
22,250
........................
15,810
* The burden hours associated with this instrument account for both new and continuation applications. Additional (uploaded) supporting documentation is included as part of this instrument and reflected in the burden hours.
** The same respondents are completing these instruments.
VerDate Sep<11>2014
19:56 Dec 20, 2022
Jkt 259001
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
E:\FR\FM\21DEN1.SGM
21DEN1
]]>Agencies
[Federal Register Volume 87, Number 244 (Wednesday, December 21, 2022)]
[Notices]
[Pages 78112-78114]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-27698]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Proposed Collection:
Public Comment Request Information Collection Request Title: Healthy
Start Evaluation and Capacity Building Support, OMB No. 0906-xxxx--New
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with of the Paperwork Reduction Act of 1995,
HRSA has submitted an Information Collection Request (ICR) to the
Office of Management and Budget (OMB) for review and approval. Comments
submitted during the first public review of this ICR will be provided
to OMB. OMB will accept further comments from the public during the
review and approval period. OMB may act on HRSA's ICR only after the
30-day comment period for this Notice has closed.
DATES: Comments on this ICR must be received no later than January 20,
2023.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under Review--Open for
Public Comments'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance
requests submitted to OMB for review, email Samantha Miller, the acting
HRSA Information Collection Clearance Officer at [email protected] or
call 301-594-4394.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title: Healthy Start Evaluation and
Capacity Building Support, OMB No. 0906-xxxx--New.
Abstract: The National Healthy Start Program, authorized by 42
U.S.C. 254c-8 (section 330H of the Public Health Service Act) and
funded through HRSA, has the goal of reducing disparities in
[[Page 78113]]
maternal and infant health. The program began as a demonstration
project with 15 grantees in 1991 and has expanded over the past 3
decades to 101 grantees across 35 states; Washington, DC; and Puerto
Rico. Healthy Start grantees operate in communities with rates of
infant mortality at least 1.5 times the U.S. national average, or with
high rates of other adverse perinatal outcomes (e.g., low birthweight,
preterm birth). Grantees may also qualify for the program if their
project areas meet other relevant criteria (e.g., high rates of
diabetes, obesity, or tobacco use during pregnancy; low utilization of
prenatal care in the first trimester; no utilization of prenatal care
during pregnancy) that demonstrate disparities in health outcomes for
pregnant women in their communities. Healthy Start programs are located
in communities that are geographically, racially, ethnically, and
linguistically diverse. Healthy Start covers services during the
perinatal period (before, during, after pregnancy) and follows the
women, infants, and fathers/partners in the program through 18 months
after the end of the pregnancy. The Healthy Start program uses a life
course approach that includes women's health, family health and
wellness, and community/population health.
HRSA seeks to implement a mixed-methods evaluation to assess the
effectiveness of the program on individual, organizational, and
community-level outcomes. Data collection instruments will include the
(1) Healthy Start Program Survey, (2) Healthy Start Network Survey, (3)
Healthy Start Participant Survey, and (4) Healthy Start Stakeholder
Interview Guide. These instruments have been specifically designed to
be non-duplicative. Using previously approved content, the Healthy
Start Program Survey is designed to collect information on the
experiences of all 101 grantee programs related to program
infrastructure, services/activities, participants, community
partnerships, new maternal and fatherhood initiatives, and health
equity. The information collected in the survey will allow the Healthy
Start grantees to better assess risk, identify needed services, provide
appropriate follow-up activities to program participants, and improve
overall service delivery and quality.
The two other surveys and interview guide will be administered to a
subset of 15 grantees, their community partners, and participants. The
Healthy Start Network Survey focuses on understanding the participation
of members in the Healthy Start Community Action Networks (CANs) \1\
and collaborations within the CANs to improve maternal, infant, and
family outcomes within the Healthy Start communities. Results from the
survey will help the Healthy Start programs and their CANs identify
areas of strength and opportunities for further collaborations,
understand how well the CAN members are working together to serve women
and their families, and whether they are supporting the programs in
addressing the participants' greatest needs. The Healthy Start
Participant Survey is designed to collect information about the
experiences of the Healthy Start participants with the program and
assess whether the programs are meeting their needs. The Healthy Start
grantees can use this information to identify areas to strengthen the
services provided to the participants. The Healthy Start Stakeholder
Interview Guide is designed to collect more in-depth information about
the Healthy Start services, the new maternal health and fatherhood
initiatives, CAN activities, and activities developed to improve the
Healthy Start benchmarks and achieve health equity.
---------------------------------------------------------------------------
\1\ A CAN is an existing, formally organized partnership of
organizations and individuals. The CAN represents consumers and
appropriate agencies which unite in an effort to collectively apply
their resources to the implementation of one or more common
strategies to achieve a common goal within that project area.
---------------------------------------------------------------------------
A 60-day notice was published in the Federal Register, 87 FR 43535
(July 21, 2022). There were no public comments.
Need and Proposed Use of the Information: The purpose of the data
collection instruments is to obtain consistent information across all
grantees about Healthy Start, its operations and outcomes. The data
will be used to (1) conduct ongoing performance monitoring of the
program; (2) provide credible and rigorous evidence of program effect
on outcomes; (3) meet program needs for accountability, programmatic
decision-making, and ongoing quality assurance; and (4) strengthen the
evidence base and identify best and promising practices for the program
to support sustainability, replication, and dissemination of the
program.
Likely Respondents: Respondents will include project directors and
staff for the Healthy Start Program Survey, members of the CANs for the
Healthy Start Network Survey, program participants for the Healthy
Start Participant Survey, and program and administrative staff for the
Healthy Start Stakeholder Interview Guide.
Burden Statement: Burden in this context means the time expended by
persons to generate, maintain, retain, disclose, or provide the
information requested. This includes the time needed to review
instructions; to utilize technology and systems for the purpose of
collecting, validating and verifying information, processing and
maintaining information, and disclosing and providing information; to
search data sources; to complete and review the collection of
information; and to transmit or otherwise disclose the information.
The total annual burden hours estimated for this ICR are summarized
in the table below. The total number of responses was multiplied by the
average burden per response and summed to produce the total annualized
burden hours, which is estimated to be 600 hours. A break-down of these
hours is detailed in the table below.
Total Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of Total burden per Total burden
Form name respondents responses per responses response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Healthy Start Program Survey.... 101 1 101 1.00 101
Healthy Start Network Survey.... \1\ 600 1 600 0.33 198
Healthy Start Participant Survey \2\ 750 1 750 0.25 188
Healthy Start Stakeholder \3\ 150 1 150 0.75 113
Interview Guide................
-------------------------------------------------------------------------------
Total....................... 1,601 .............. 1,601 .............. 600
----------------------------------------------------------------------------------------------------------------
\1\ This is the maximum number of responses for this data collection instrument.
[[Page 78114]]
\2\ Ibid.
\3\ Ibid.
HRSA specifically requests comments on (1) the necessity and
utility of the proposed information collection for the proper
performance of the agency's functions; (2) the accuracy of the
estimated burden; (3) ways to enhance the quality, utility, and clarity
of the information to be collected; and (4) the use of automated
collection techniques or other forms of information technology to
minimize the information collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022-27698 Filed 12-20-22; 8:45 am]
BILLING CODE 4165-15-P
